# International Flavors & Fragrances Inc: financial statements, quarterly

IFF · NYSE · CIK 51253 · [Materials](/sectors/materials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/iff.md) · [Financials](/companies/iff/financials.md) · [Filings](/companies/iff/filings.md) · [Insiders](/companies/iff/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/iff/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [2,820](/filings/0000051253-24-000042.md) | [2,703 d](/filings/0000051253-26-000006.md) | [2,899](/filings/0000051253-25-000027.md) | [2,889](/filings/0000051253-25-000042.md) | [2,925](/filings/0000051253-26-000006.md) | [2,771](/filings/0000051253-26-000006.md) | [2,843](/filings/0000051253-26-000017.md) | [1,919](/filings/0000051253-26-000030.md) | [2,694](/filings/0000051253-25-000049.md) | [2,589 d](/filings/0000051253-26-000006.md) | [2,741](/filings/0000051253-26-000017.md) | [1,954](/filings/0000051253-26-000030.md) |
| Cost of revenue | $m | [1,896](/filings/0000051253-24-000042.md) | [1,843 d](/filings/0000051253-26-000006.md) | [1,875](/filings/0000051253-25-000027.md) | [1,821](/filings/0000051253-25-000042.md) | [1,873](/filings/0000051253-25-000049.md) | [1,791 d](/filings/0000051253-26-000006.md) | [1,808](/filings/0000051253-26-000017.md) | [1,095](/filings/0000051253-26-000030.md) | [1,711](/filings/0000051253-25-000049.md) | [1,699 d](/filings/0000051253-26-000006.md) | [1,723](/filings/0000051253-26-000017.md) | [1,101](/filings/0000051253-26-000030.md) |
| Gross profit | $m | [924](/filings/0000051253-24-000042.md) | [860 d](/filings/0000051253-26-000006.md) | [1,024](/filings/0000051253-25-000027.md) | [1,068](/filings/0000051253-25-000042.md) | [1,052](/filings/0000051253-26-000006.md) | [980](/filings/0000051253-26-000006.md) | [1,035](/filings/0000051253-26-000017.md) | [824](/filings/0000051253-26-000030.md) | [983](/filings/0000051253-25-000049.md) | [890 d](/filings/0000051253-26-000006.md) | [1,018](/filings/0000051253-26-000017.md) | [853](/filings/0000051253-26-000030.md) |
| Research and development | $m | [157](/filings/0000051253-24-000042.md) | [157 d](/filings/0000051253-26-000006.md) | [166](/filings/0000051253-25-000027.md) | [173](/filings/0000051253-25-000042.md) | [162](/filings/0000051253-25-000049.md) | [170 d](/filings/0000051253-26-000006.md) | [164](/filings/0000051253-26-000017.md) | [170](/filings/0000051253-26-000030.md) | [174](/filings/0000051253-25-000049.md) | [174 d](/filings/0000051253-26-000006.md) | [166](/filings/0000051253-26-000017.md) | [170](/filings/0000051253-26-000030.md) |
| Selling, general and administrative | $m | [444](/filings/0000051253-24-000042.md) | [444 d](/filings/0000051253-26-000006.md) | [490](/filings/0000051253-25-000027.md) | [493](/filings/0000051253-25-000042.md) | [495](/filings/0000051253-25-000049.md) | [517 d](/filings/0000051253-26-000006.md) | [461](/filings/0000051253-26-000017.md) | [409](/filings/0000051253-26-000030.md) | [421](/filings/0000051253-25-000049.md) | [469 d](/filings/0000051253-26-000006.md) | [427](/filings/0000051253-26-000017.md) | [437](/filings/0000051253-26-000030.md) |
| Operating income | $m | [150](/filings/0000051253-24-000042.md) | [(2,536) d](/filings/0000051253-26-000006.md) | [199](/filings/0000051253-25-000027.md) | [191](/filings/0000051253-25-000042.md) | [249](/filings/0000051253-25-000049.md) | [127 d](/filings/0000051253-26-000006.md) | [(903)](/filings/0000051253-26-000017.md) | [142](/filings/0000051253-26-000030.md) | [226](/filings/0000051253-25-000049.md) | [97.0 d](/filings/0000051253-26-000006.md) | [273](/filings/0000051253-26-000017.md) | [158](/filings/0000051253-26-000030.md) |
| Interest expense | $m | [90.0](/filings/0000051253-24-000042.md) | [89.0 d](/filings/0000051253-24-000006.md) | [83.0](/filings/0000051253-25-000027.md) | [79.0](/filings/0000051253-25-000042.md) | [74.0](/filings/0000051253-25-000049.md) | [69.0 d](/filings/0000051253-26-000006.md) | [71.0](/filings/0000051253-26-000017.md) | [61.0](/filings/0000051253-26-000030.md) | [48.0](/filings/0000051253-25-000049.md) | [49.0 d](/filings/0000051253-26-000006.md) | [44.0](/filings/0000051253-26-000017.md) | [46.0](/filings/0000051253-26-000030.md) |
| Income tax | $m | [32.0](/filings/0000051253-24-000042.md) | [(8.0) d](/filings/0000051253-26-000006.md) | [54.0](/filings/0000051253-25-000027.md) | [11.0](/filings/0000051253-25-000042.md) | [36.0](/filings/0000051253-25-000049.md) | [(55.0) d](/filings/0000051253-26-000006.md) | [23.0](/filings/0000051253-26-000017.md) | [(112)](/filings/0000051253-26-000030.md) | [15.0](/filings/0000051253-25-000049.md) | [(9.0) d](/filings/0000051253-26-000006.md) | [39.0](/filings/0000051253-26-000017.md) | [31.0](/filings/0000051253-26-000030.md) |
| Net income | $m | [25.0](/filings/0000051253-24-000042.md) | [(2,630) d](/filings/0000051253-26-000006.md) | [60.0](/filings/0000051253-25-000027.md) | [170](/filings/0000051253-25-000042.md) | [58.0](/filings/0000051253-25-000049.md) | [(56.0) d](/filings/0000051253-26-000006.md) | [(1,018)](/filings/0000051253-26-000017.md) | [599](/filings/0000051253-26-000030.md) | [40.0](/filings/0000051253-25-000049.md) | [33.0 d](/filings/0000051253-26-000006.md) | [169](/filings/0000051253-26-000017.md) | [50.0](/filings/0000051253-26-000030.md) |
| Diluted EPS | $ per share | [0.10](/filings/0000051253-24-000042.md) | not reported | [0.23](/filings/0000051253-25-000027.md) | [0.66](/filings/0000051253-25-000042.md) | [0.23](/filings/0000051253-25-000049.md) | not reported | [(3.98)](/filings/0000051253-26-000017.md) | [2.33](/filings/0000051253-26-000030.md) | [0.16](/filings/0000051253-25-000049.md) | not reported | [0.66](/filings/0000051253-26-000017.md) | [0.20](/filings/0000051253-26-000030.md) |
| Basic EPS | $ per share | [0.10](/filings/0000051253-24-000042.md) | not reported | [0.23](/filings/0000051253-25-000027.md) | [0.67](/filings/0000051253-25-000042.md) | [0.23](/filings/0000051253-25-000049.md) | not reported | [(3.98)](/filings/0000051253-26-000017.md) | [2.34](/filings/0000051253-26-000030.md) | [0.16](/filings/0000051253-25-000049.md) | not reported | [0.66](/filings/0000051253-26-000017.md) | [0.20](/filings/0000051253-26-000030.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss, us-gaap:ProfitLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [0.6](/filings/0000051253-24-000042.md) | [0.7](/filings/0000051253-26-000006.md) | [0.7](/filings/0000051253-25-000027.md) | [0.7](/filings/0000051253-25-000042.md) | [0.6](/filings/0000051253-25-000049.md) | [0.5](/filings/0000051253-26-000030.md) | [0.6](/filings/0000051253-26-000017.md) | [0.8](/filings/0000051253-26-000030.md) | [0.6](/filings/0000051253-25-000049.md) | [0.6](/filings/0000051253-26-000030.md) | [0.6](/filings/0000051253-26-000017.md) | [0.6](/filings/0000051253-26-000030.md) |
| Current assets | $bn | [6.4](/filings/0000051253-23-000036.md) | [6.3](/filings/0000051253-25-000013.md) | [6.4](/filings/0000051253-24-000016.md) | [8.1](/filings/0000051253-24-000032.md) | [8.4](/filings/0000051253-24-000042.md) | [8.0](/filings/0000051253-26-000006.md) | [8.6](/filings/0000051253-25-000027.md) | [5.9](/filings/0000051253-25-000042.md) | [5.9](/filings/0000051253-25-000049.md) | [5.6](/filings/0000051253-26-000030.md) | [5.4](/filings/0000051253-26-000017.md) | [9.1](/filings/0000051253-26-000030.md) |
| Total assets | $bn | [33.4](/filings/0000051253-23-000036.md) | [31.0](/filings/0000051253-25-000013.md) | [30.6](/filings/0000051253-24-000016.md) | [29.5](/filings/0000051253-24-000032.md) | [29.9](/filings/0000051253-24-000042.md) | [28.7](/filings/0000051253-26-000006.md) | [28.3](/filings/0000051253-25-000027.md) | [26.1](/filings/0000051253-25-000042.md) | [25.8](/filings/0000051253-25-000049.md) | [25.5](/filings/0000051253-26-000030.md) | [25.1](/filings/0000051253-26-000017.md) | [25.2](/filings/0000051253-26-000030.md) |
| Current liabilities | $bn | [3.7](/filings/0000051253-23-000036.md) | [3.8](/filings/0000051253-25-000013.md) | [3.8](/filings/0000051253-24-000016.md) | [3.4](/filings/0000051253-24-000032.md) | [3.2](/filings/0000051253-24-000042.md) | [4.4](/filings/0000051253-26-000006.md) | [4.6](/filings/0000051253-25-000027.md) | [3.2](/filings/0000051253-25-000042.md) | [4.1](/filings/0000051253-25-000049.md) | [3.9](/filings/0000051253-26-000030.md) | [3.6](/filings/0000051253-26-000017.md) | [4.4](/filings/0000051253-26-000030.md) |
| Long-term debt | $bn | [9.2](/filings/0000051253-23-000036.md) | [9.2](/filings/0000051253-25-000013.md) | [9.2](/filings/0000051253-24-000016.md) | [8.6](/filings/0000051253-24-000032.md) | [8.6](/filings/0000051253-24-000042.md) | [7.6](/filings/0000051253-26-000006.md) | [7.6](/filings/0000051253-25-000027.md) | [5.7](/filings/0000051253-25-000042.md) | [4.7](/filings/0000051253-25-000049.md) | [4.7](/filings/0000051253-26-000030.md) | [4.7](/filings/0000051253-26-000017.md) | [4.7](/filings/0000051253-26-000030.md) |
| Current portion of debt | $bn | [1.1](/filings/0000051253-23-000036.md) | [0.9](/filings/0000051253-25-000013.md) | [1.1](/filings/0000051253-24-000016.md) | [0.8](/filings/0000051253-24-000032.md) | [0.5](/filings/0000051253-24-000042.md) | [1.4](/filings/0000051253-26-000006.md) | [1.7](/filings/0000051253-25-000027.md) | [0.5](/filings/0000051253-25-000042.md) | [1.3](/filings/0000051253-25-000049.md) | [1.3](/filings/0000051253-26-000030.md) | [1.1](/filings/0000051253-26-000017.md) | [1.0](/filings/0000051253-26-000030.md) |
| Short-term borrowings | $bn | [0.0](/filings/0000051253-23-000036.md) | [0.0](/filings/0000051253-25-000013.md) | [0.8](/filings/0000051253-24-000016.md) | [0.2](/filings/0000051253-24-000032.md) | [0.0](/filings/0000051253-24-000042.md) | [0.0](/filings/0000051253-26-000006.md) | [0.3](/filings/0000051253-25-000027.md) | not reported | [0.4](/filings/0000051253-25-000049.md) | [0.3](/filings/0000051253-26-000030.md) | [0.2](/filings/0000051253-26-000017.md) | [0.1](/filings/0000051253-26-000030.md) |
| Shareholders' equity | $bn | [17.0](/filings/0000051253-23-000036.md) | [14.6](/filings/0000051253-25-000013.md) | [14.3](/filings/0000051253-24-000016.md) | [14.3](/filings/0000051253-24-000032.md) | [14.8](/filings/0000051253-24-000042.md) | [13.8](/filings/0000051253-26-000006.md) | [13.2](/filings/0000051253-25-000027.md) | [14.4](/filings/0000051253-25-000042.md) | [14.2](/filings/0000051253-25-000049.md) | [14.2](/filings/0000051253-26-000030.md) | [14.1](/filings/0000051253-26-000017.md) | [14.0](/filings/0000051253-26-000030.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Short-term borrowings: us-gaap:CommercialPaper
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [420 d](/filings/0000051253-24-000042.md) | [660 d](/filings/0000051253-26-000006.md) | [99.0](/filings/0000051253-25-000027.md) | [237 d](/filings/0000051253-25-000042.md) | [345 d](/filings/0000051253-25-000049.md) | [389 d](/filings/0000051253-26-000006.md) | [127](/filings/0000051253-26-000017.md) | [241 d](/filings/0000051253-26-000030.md) | [164 d](/filings/0000051253-25-000049.md) | [318 d](/filings/0000051253-26-000006.md) | [257](/filings/0000051253-26-000017.md) | [422 d](/filings/0000051253-26-000030.md) |
| Capital expenditure | $m | [100 d](/filings/0000051253-24-000042.md) | [113 d](/filings/0000051253-26-000006.md) | [118](/filings/0000051253-25-000027.md) | [82.0 d](/filings/0000051253-25-000042.md) | [103 d](/filings/0000051253-25-000049.md) | [160 d](/filings/0000051253-26-000006.md) | [179](/filings/0000051253-26-000017.md) | [95.0 d](/filings/0000051253-26-000030.md) | [132 d](/filings/0000051253-25-000049.md) | [188 d](/filings/0000051253-26-000006.md) | [165](/filings/0000051253-26-000017.md) | [136 d](/filings/0000051253-26-000030.md) |
| Dividends paid | $m | [206 d](/filings/0000051253-24-000042.md) | [207 d](/filings/0000051253-26-000006.md) | [207](/filings/0000051253-25-000027.md) | [102 d](/filings/0000051253-25-000042.md) | [102 d](/filings/0000051253-25-000049.md) | [103 d](/filings/0000051253-26-000006.md) | [102](/filings/0000051253-26-000017.md) | [102 d](/filings/0000051253-26-000030.md) | [102 d](/filings/0000051253-25-000049.md) | [103 d](/filings/0000051253-26-000006.md) | [102](/filings/0000051253-26-000017.md) | [102 d](/filings/0000051253-26-000030.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | [0.0](/filings/0000051253-26-000017.md) | [0.0 d](/filings/0000051253-26-000030.md) | not reported | not reported | [35.0](/filings/0000051253-26-000017.md) | [36.0 d](/filings/0000051253-26-000030.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [255](/filings/0000051253-23-000036.md) | [255](/filings/0000051253-24-000016.md) | [255](/filings/0000051253-24-000032.md) | [256](/filings/0000051253-24-000042.md) | [256](/filings/0000051253-25-000027.md) | [256](/filings/0000051253-25-000042.md) | [257](/filings/0000051253-25-000049.md) | [256](/filings/0000051253-26-000017.md) | [257](/filings/0000051253-26-000030.md) | [257](/filings/0000051253-25-000049.md) | [257](/filings/0000051253-26-000017.md) | [257](/filings/0000051253-26-000030.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 255,149,963 at 2026-07-31, from the cover of the [10-Q filed 2026-08-04](/filings/0000051253-26-000030.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:19 ET. No prices; not investment advice.